Back
Alnylam Pharmaceuticals Stock Price Chart
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
149.30
Seasonality Move:
19.79%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.99 | Sell |
| 20-day SMA: | 148.6 | Buy |
| 50-day SMA: | 149.26 | Buy |
| 200-day SMA: | 169.18 | Sell |
| 8-day EMA: | 149.7 | Sell |
| 20-day EMA: | 149.44 | Sell |
| 50-day EMA: | 151.58 | Sell |
| 200-day EMA: | 167.28 | Sell |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 49.64 | Sell |
| Chaikin Money Flow: | -157058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.92 - 151.18) | Buy |
| Bollinger Bands (100): | (144.43 - 179.11) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.40 while ALNY 8-day simple moving average is 149.99, which is a Sell signal.
- The stock price of ALNY is 149.40 while Alnylam Pharmaceuticals 20-day SMA is 148.60, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 149.26 while ALNY share price is 149.40, making it a Buy technically.
- ALNY stock price is 149.40 and Alnylam Pharmaceuticals 200-day simple moving average is 169.18, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $149.40. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
18.9B
Price in USD:
149.40
Share Volume:
406.5K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
218.88
52-Week Low:
141.98
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 149.40 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.40 while ALNY 8-day exponential moving average is 149.70, which is a Sell signal.
- The stock price of ALNY is 149.40 while Alnylam Pharmaceuticals 20-day EMA is 149.44, which makes it a Sell.
- Alnylam Pharmaceuticals 50-day exponential moving average is 151.58 while ALNY share price is 149.40, making it a Sell technically.
- ALNY stock price is 149.40 and Alnylam Pharmaceuticals 200-day simple moving average is 167.28, creating a Sell signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Alnylam Pharmaceuticals is a Buy
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 49.64, which suggest Alnylam Pharmaceuticals is oversold
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (144.92 - 151.18), which suggest Alnylam Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (144.43 - 179.11), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.